Reference no: EM133645403

Question 

The Canadian Cardiovascular Society (2021) recommends quadruple therapy for patients with heart failure with a reduced ejection fraction: Angiotensin Receptor/Neprilysin Inhibitor (ARNI), Beta-blocker, Mineralocorticoid Receptor Antagonist (MRA), and Sodium-Glucose Cotransporter-2 (SGLT2 Inhibitor) as tolerated (p. 10).

Question: Why do you think the cardiologist continued his Vitamin D but discontinued his proton pump inhibitor and ordered acetaminophen instead of a non-steroidal anti-inflammatory like ibuprofen? Hello, today we are visiting Mr. Lowell at his home in a senior's apartment building. He is 82 years of age. His wife Althea passed 5 years ago. We visit him twice a week to offer support with his activities of daily living. He lives with heart failure and hypertension and uses a 4-wheeled walker for his mobility. He is at risk of falling. He wears a hearing aid in his left ear and wears glasses for reading. He wears compression stockings during the day and removes them at night before bed. He follows a healthy heart diet, low sodium, with a 1.5L fluid restriction. What information did you learn about Mr. Lowell from the team report?